J&J
J&J launches lawsuit to block release of Remicade biosimilar
May 19, 2017Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis
Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …
FDA demands new warnings for J&J diabetes drug over amputation risk
May 17, 2017Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes
Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
J&J ordered to pay $5m over false marketing claims
April 6, 2017Sales and Marketing J&J, JJ, lawsuit
Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …
Closure of Scottish J&J plant threatens 400 staff
March 10, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson has announced its intention to shut down its surgical suture manufacturing facility in Livingston, Scotland which sees …
Lilly posts impressive psoriasis results in comparison study
March 6, 2017Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly
Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …
J&J latest pharma firm to volunteer pricing data
February 28, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …
Integra bids $1.045 billion for J&J’s neurosurgery business
February 16, 2017Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson
Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …
J&J breast implants “may have harmed thousands”, claims fresh lawsuit
February 6, 2017Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants
Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
J&J hit by $1bn hip implant lawsuit
December 2, 2016Medical Communications J&J, JJ, lawsuit
Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …
J&J reportedly poised to acquire Europe’s biggest biotech
November 25, 2016Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition
Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …
Janssen’s Crohn’s treatment licensed for UK use
November 16, 2016Research and Development, Sales and Marketing Chrohn's disease, J&J, JJ, Janssen, Johnson & Johnson, Stelara
Janssen, a subsidiary of Johnson & Johnson, has announced that its treatment Stelara (ustekinumab) is now licensed by the European …
Collaboration on new therapeutic vaccine for HIV shows promise
November 10, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, J&J, JJ, Janssen, Johnson & Johnson
Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …
Pfizer sets release date for rival to J&J’s blockbuster drug
October 18, 2016Manufacturing and Production J&J, JJ, Johnson & Johnson, Pfizer, Remicade, inflectra
Pfizer have announced that they will begin shipping their rival to Johnson & Johnson’s Remicade by the end of November. …
Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
Latest content
